{"id":"NCT02271217","sponsor":"Acorda Therapeutics","briefTitle":"A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.","officialTitle":"This is a Multi-center, Double-blind, Three Arm, Parallel Group, Placebo-controlled, Randomized Study Designed to Evaluate the Efficacy, Safety and Tolerability of Dalfampridine.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12","primaryCompletion":"2016-09","completion":"2016-10","firstPosted":"2014-10-22","resultsPosted":"2017-12-04","lastUpdate":"2018-06-07"},"enrollment":377,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Post-Ischemic Stroke"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"dalfampridine-ER 7.5mg","otherNames":[]},{"type":"DRUG","name":"dalfampridine-ER 10mg","otherNames":["Ampyra"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"dalfampridine-ER 7.5 mg","type":"ACTIVE_COMPARATOR"},{"label":"dalfampridine-ER 10mg","type":"ACTIVE_COMPARATOR"}],"summary":"The objective of this study is to determine the effect of two dose strengths of dalfampridine-Extended Release (ER) tablets, taken twice daily for 12 weeks, on stable walking deficits in subjects with post-ischemic stroke.","primaryOutcome":{"measure":"Proportion of Subjects Who Show at Least a 20% Improvement on the Two Minute Walk Test (2MinWT) at Week 12","timeFrame":"Week 12","effectByArm":[{"arm":"Placebo","deltaMin":17,"sd":null},{"arm":"Dalfampridine-ER 7.5 mg","deltaMin":17,"sd":null},{"arm":"Dalfampridine-ER 10mg","deltaMin":23,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":74,"countries":["United States","Canada"]},"refs":{"pmids":["32651338"],"seeAlso":["http://milestone.acordatrials.com/"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":126},"commonTop":["Fall","Urinary Tract Infection","Dizziness","Fatigue","Nasopharyngitis"]}}